- Home
- BELFB vs VCYT Comparison
BELFB vs VCYT Comparison
Compare BELFB & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BELFB | VCYT |
|---|---|---|
| Founded | 1949 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BELFB | VCYT |
|---|---|---|
| Price | $258.93 | $47.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $329.67 | $58.42 |
| AVG Volume (30 Days) | 107.0K | ★ 1.3M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.11% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $491,611,000.00 | N/A |
| Revenue This Year | $20.02 | $14.80 |
| Revenue Next Year | $8.25 | $11.21 |
| P/E Ratio | ★ $42.80 | $72.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $129.94 | $29.46 |
| 52 Week High | $335.29 | $60.91 |
Technical Indicators
Market Signals| Indicator | BELFB | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 57.87 |
| Support Level | $243.05 | $46.04 |
| Resistance Level | $289.40 | $49.77 |
| Average True Range (ATR) | 8.26 | 2.67 |
| MACD | 2.34 | 0.67 |
| Stochastic Oscillator | 92.51 | 86.05 |
Price Performance
Historical ComparisonAbout BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).